Clinical Trials
3 trialsNCT04364178 2026-05-27
Viral Specific T-Lymphocytes to Treat Adenovirus, CMV and EBV
Stanford University
Phase 1/2 Terminated
NCT05011058 2025-07-28
NAVAL-1
Viracta Therapeutics, Inc.
Phase 2 Terminated
NCT00001379 2025-06-19
Treatment and Natural History Study of Lymphomatoid Granulomatosis
National Institutes of Health Clinical Center (CC)
Phase 2 Completed